BT-7480 by Bicycle Therapeutics for Solid Tumor: Likelihood of Approval

BT-7480 is under clinical development by Bicycle Therapeutics and currently in Phase II for Solid Tumor.

DNA test that predicts opioid addiction should be pulled off the market, critics urge the FDA

In the next 24 hours, more than 130 people will die from opioid-related drug overdoses. That will happen again tomorrow and the next day. Each

April 4, 2024

Cheap Drug Eases Hot Flashes in Men With Prostate Cancer

CHICAGO — A widely available anticholinergic significantly improved hot flash symptoms in men taking androgen deprivation therapy (ADT) for their prostate cancer, a researcher reported

June 4, 2024

Decoding how bats distinguish sounds for navigation and communication

Seba’s short-tailed bat (Carollia perspicillata) lives in the subtropical and tropical forests of Central and South America, where it mostly feeds on pepper fruit.

February 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.